May
Medicinal Chemistry
Strategy Meeting East Coast USA 2026
Reinvigorating Productivity in Pharma Biotech Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms
Le Meridien Cambridge BostonWhat makes our strategy meetings unique?
Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.
Claire Elizabeth Smith
Partner SpringTide Ventures
George Naumov
Chief Operations Officer & Chief Business Officer RS Oncology
Jeff Norenberg
Co-Founder & Chief Executive Officer iSeek Biopharma
Lijuan Jiang
Vice President, DMPK & Bioanalysis Enanta Pharmaceuticals
Matt Bursavich
Associate Vice President, Chemical Sciences Eli Lilly
Rocky Goldsmith
Chief Innovation Scientist / Co-Founder Congruence Therapeutics
Stephanie Oestreich
Managing Director Myeloma Investment Fund
Sridhar Narayan
Vice President Drug Discovery and Program Leadership Satellos Bioscience Inc.OUR PAST AGENDA
See Which Topics Are Discussed at the Strategy Meeting
Roundtable Tracks
1Generative Chemistry in Action: Applications, Challenges, and Breakthroughs
-Govinda Bhisetti
Vice President and Head of Computational Chemistry
Cellarity
Design, Synthesis & Emerging Modalities
Unlocking the Chemical Universe: The Power of DNA-Encoded Libraries in Drug Discovery
-Hajnalka Hartl
Head of Chemistry
Orogen Therapeutics
Chemical Biology, Targeted Protein Degradation And Undruggables
Leveraging Chemical Biology and Proteomics Technologies to Advance Therapeutics for Intractable Targets
-Hua Xu
Director, Head of Chemical Biology and Proteomics
AstraZeneca
Hit Identification / Lead Optimization
Fragment Based Drug Discovery
-Stefan Gross
Senior Director and Head of Biochemistry
Servier Pharmaceuticals
Strategic Partnerships In Drug Discovery
Beyond Algorithms: Forging Strategic Alliances to Power the AI Revolution in Drug Discovery
-Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center
Boston University
Integrated Drug Discovery
From Hit to Lead: Accelerating Drug Discovery Through Cutting-Edge Chemistry and Innovative Screening Strategies
-Shankar Venkatraman
Executive Director, Chemistry
IFM Therapeutics
Roundtable Tracks
2Emerging Challenges in Machine Learning (ML) -Driven Molecular Property Predictions
Sponsor
Design, Synthesis & Emerging ModalitiesNavigating Multi-Dimensional Complexity in Emerging Modalities: How Integrated Platforms Are Transforming PROTACs and ADC Development
-Nicolas Triballeau, Ph.D
Director
Revvity Signals
REVVITY SIGNALS
Chemical Biology, Targeted Protein Degradation And UndruggablesTargeted Protein Degradation
-Dr. Tao Guo
SVP and Head
WuXi AppTec
WUXI APPTEC
Hit Identification / Lead OptimizationLead optimisation of proximity inducing modalities
-Jon Seal
Associate Director of Medicinal Chemistry
SAI Life Sciences
SAI LIFE SCIENCES
Strategic Partnerships In Drug DiscoveryUnlocking the Power of Partnership in Drug Discovery
-Kelly Barrett
Business Development Professional
SAI Life Sciences
SAI LIFE SCIENCES
Integrated Drug DiscoveryThe Data Integration Crisis in Drug Discovery: Why Scientists Spend 60% of Their Time on Data Wrangling Instead of Breakthrough Science
-Samantha Jeschonek Ph.D.
Sr. Product Manager Data Analytics
Revvity Signals
REVVITY SIGNALS
Roundtable Tracks
3Explainable AI (XAI) and ML/AL as assistive intelligence to support rational lead optimization of small molecules
-Rocky Goldsmith
Chief Innovation Scientist / Co-Founder
Congruence Therapeutics
Design, Synthesis & Emerging Modalities
Rational Design Meets Fragmentation: Bridging Structural Biology and Fragment-Based Discovery for Novel Therapeutic Modalities
-Shankar Venkatraman
Executive Director, Chemistry
IFM Therapeutics
Chemical Biology, Targeted Protein Degradation And Undruggables
From PROTACs to RNA-Modulated Degraders: Engineering Novel Therapeutics for Hard-to-Target Proteins
-Benoit Moreau
Head of Medicinal Chemistry
Remix Therapeutics
Hit Identification / Lead Optimization
Drugging Protein:Protein Interactions: Best practices in hit identification and lead optimization of undruggable complexes
-Aimee Usera
Senior Vice President Drug Discovery
Odyssey Therapeutics
Strategic Partnerships In Drug Discovery
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery (Topic TBC)
-Huseyin Mehmet
Executive Director, New Ventures
University of Massachusetts Medical School
Integrated Drug Discovery
Augmented Discovery: How Revvity Signals’ AI/ML Amplifies Scientific Discovery
Roundtable Tracks
4Fast-Tracking Innovation: Leveraging AI/ML to Accelerate Drug Discovery
-Markus Haeberlein
Executive Vice President, Discovery Science
Parabilis Medicines
Design, Synthesis & Emerging Modalities
Computational & AI-Driven TAA Discovery for Bispecific and Small Molecule ADC Development
-Lu Gong
Head of Bioinformatics and AI
Simcere Pharma
Chemical Biology, Targeted Protein Degradation And Undruggables
Induced Proximity Therapeutics: Drugging Disease Drivers Through Engineered Protein Protein Interaction Enhancers
-Matthew Lucas
VP of Medical Chemistry
Third Harmonic Bio
Hit Identification / Lead Optimization
The Impact of AI and Large Language Models Across the Drug Discovery Pipeline
-Lee Fader
Vice President
Congruence Therapeutics
Strategic Partnerships In Drug Discovery
The Role of Venture Partnerships in Drug Discovery
-Richard Heidebrecht
Vice President of Research and Development
Glycologix
Integrated Drug Discovery
Rewriting the Rules of Therapeutics: The Expanding Frontier of RNA Drug Discovery
-Jennifer Petter
Founder and Chief Scientific Officer
Arrakis Therapeutics
Reasons To Attend the Strategy Meeting
Discussions on the advancements in targeted protein degradation and pushing past its boundaries.
Leveraging Artificial Intelligence and Machine Learning in accelerating the development of new drugs
Discuss approaches to further understand the interactions of undruggable targets and different Protein Degraders such as PROTACs, Molecular Glues, etc
Focusing on advancing interrogative techniques to improve the Drug Delivery System/Discovery: Modified mRNA, Nanoparticle-Mediated siRNA, Antibody-Drug Conjugates, and more
Our Past Sponsors
Lead Sponsor
Thought Leader
Co-Host Sponsor
Partnering Sponsors
Exhibitor
Media Partner
Explore Highlight From The Past Events
Gain valuable insights, discover innovative solutions and connect with industry leaders through snapshots of our most successful gatherings.
Event Gallery
Watch to hear what your colleagues had to say…
Hotel & Venue
Le Méridien Boston Cambridge
Le Méridien Cambridge-MIT’s elegant guest rooms and suites offer a place of luxurious sanctuary and unmatched comfort. Explore unique programs inspired by the brand’s European heritage. Born in a glamorous era of travel, Le Méridien believes everyone should explore the world in style.
Hotel Details Maps & Direction Parking
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.
Registering online is quick and easy. Simply click the appropriate button below to start the registration process:
- About you
- About your company
- Payment
About Your Company
This is required field*
This is required field*
This is required field*
This is required field*
This is required field*
This is required field*
This is required field*
This is required field*
1*** Please read our Terms of Service and Privacy Policy
No need to enter card details.
Card details
Thanks for your order!
Your registration was successful. You should receive an email shortly confirming your order.
We’re processing your registration and you will recieve further information within 48hours. If you would like a full receipt please email accounts@proventainternational.co.uk
Please quote this when emailing or calling us for any booking related enquires.
Something went wrong. Try again!
Something wasn’t quite right. You can try to make a card payment again otherwise please get in touch at registration@proventainternational.com
Please quote this when emailing or calling us for any booking related enquires.
Order summary for
Bioprocesses Oncology Europe
Payment Securely powered by stripe
